What Aspergillosis Patients Need to Know**
Part of the Aspergillosis Immune System Knowledge Hub
Eosinophils are a type of white blood cell central to allergy, asthma, and ABPA. They play a major role in symptoms, flare-ups, mucus plugging, and treatment responses.
This article explains eosinophils in simple terms.
🧬 1. What Are Eosinophils?
Eosinophils are immune cells filled with granules containing powerful enzymes.
They normally help:
-
fight parasites
-
regulate allergic inflammation
-
repair tissues
-
produce important immune signals
But in excess, they can cause damage — especially in the lungs.
🔥 2. Eosinophils in the Lungs
Activated eosinophils release their granules into airway tissues, causing:
-
swelling
-
increased mucus
-
airway narrowing
-
cough sensitivity
-
wheezing
-
breathlessness
This makes them key players in allergic and fungal-related lung disease.
🌟 3. Eosinophils in ABPA
Eosinophils are highly active in ABPA.
ABPA involves a strong “type-2” allergic response to Aspergillus, including:
-
high IgE
-
mast cell activation
-
large numbers of eosinophils
-
thick, sticky mucus
-
airway obstruction
-
repeated flare-ups
Eosinophils contribute significantly to long-term lung damage if not controlled.
🌬 4. Eosinophils in Severe Asthma and SAFS
In severe or allergic asthma:
-
eosinophils can be persistently high
-
they drive airway swelling
-
they increase sensitivity to triggers
-
they worsen recovery after infection
In SAFS, eosinophils may be moderately raised but symptoms can still be severe.
🦠5. Eosinophils in CPA
In CPA, eosinophils are not usually the dominant cell, but they still matter when patients also have:
-
asthma
-
ABPA overlap
-
fungal allergy
-
airway hypersensitivity
-
steroid withdrawal flare-ups
đź”— 6. How Eosinophils Link to Other Immune Cells
They interact with:
-
IgE → recruits eosinophils
-
T-helper cells (Th2) → tell bone marrow to make more
-
Mast cells → release histamine that pulls eosinophils into tissues
-
Airway lining cells → release distress signals
This is why severe allergic pathways often involve all three:
IgE → mast cells → eosinophils
đź’Š 7. Treatments That Target Eosinophils
âś” Steroids (oral or inhaled)
Suppress eosinophil activity.
âś” Biologics
Directly reduce eosinophils:
-
Mepolizumab (anti-IL-5)
-
Benralizumab (anti-IL-5 receptor)
-
Reslizumab (anti-IL-5 infusion)
Reduce eosinophil recruitment:
-
Dupilumab (anti-IL-4/IL-13)
-
Tezepelumab (broad upstream suppression)
These can transform life for patients with severe asthma or ABPA.
đź§ 8. Summary
Eosinophils are key drivers of:
-
flare-ups
-
mucus plugging
-
wheeze
-
breathlessness
-
airway damage
Understanding them helps patients:
-
interpret blood tests
-
understand biologic treatments
-
recognise flare-up patterns
-
manage ABPA and asthma more confidently
Next articles:
Share this post
Latest News posts
Watch the World Aspergillosis Day 2026 talks
March 2, 2026
Using AI Safely When You Have Aspergillosis
March 2, 2026
Isavuconazole in Aspergillosis
February 20, 2026
Posaconazole in Aspergillosis
February 20, 2026
Voriconazole in Aspergillosis
February 20, 2026
Aspergillosis Literature Update: Week 5
February 16, 2026
🧬 How Biologics Are Reshaping Our Understanding of ABPA Subtypes
February 13, 2026
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Specialists
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
